TORONTO, April 4, 2014 /CNW/ - Queen's University and the Canadian
Cancer Society are pleased to announce that Dr Janet Dancey will be the
next director of the NCIC Clinical Trials Group (NCIC CTG) effective
September 1, 2014.
"I am honoured to have the opportunity to lead the NCIC CTG and work
with such a dedicated group of people at Queen's, across Canada and
around the world," says Dr Dancey. "The NCIC CTG is a world-class
cancer clinical trials group, and the results of the trials it conducts
are important for cancer patients both today and tomorrow as they lead
to advances in cancer care. There is tremendous opportunity to improve
outcomes for patients through personalized medicine strategies and to
develop new approaches to trial design and execution."
A professor in the Department of Oncology at Queen's, Dr Dancey is known
internationally for her expertise in new anticancer drug development,
linking drug and biomarker development and clinical trials methodology.
"Cancer research is a cornerstone of research activity at Queen's, and
we are delighted to have Janet Dancey as the next director of the NCIC
CTG," says Dr Richard Reznick, Dean of Queen's Faculty of Health
Sciences. "She is one of this country's most respected oncologists and
known internationally in the field of cancer clinical trials. She has
an exceptional record of achievement as a scientist. I am confident
that her leadership will have a significant impact on the continued
success of the NCIC CTG."
"This is a very important leadership position for cancer research in
Canada, and we are delighted that Janet has accepted the appointment,"
says Pamela C. Fralick, President and CEO, Canadian Cancer Society.
"She brings a wealth of experience in all aspects of clinical trials to
the position, and we anticipate many years of successful collaboration.
We look forward to the evolution and growth of the NCIC CTG under
After receiving her MD from the University of Ottawa in 1988, Dr Dancey
completed her residency training in internal medicine and medical
oncology at the University of Toronto. She then did fellowship training
with the NCIC CTG and at the Institut Gustave Roussy in France.
Prior to joining the NCIC CTG, she was associate chief of the
Investigational Drug Branch in the Cancer Therapy Evaluation Program at
the US National Cancer Institute where she coordinated the development
of over 200 phase I-III trials in experimental therapeutics. She
currently divides her time between the NCIC CTG and the Ontario
Institute for Cancer Research (OICR). She is director of Clinical
Translational Research at the NCIC CTG, director of the High Impact
Clinical Trials Program at OICR, scientific director of the Canadian
Cancer Clinical Trials Network (3CTN), and chair of the Experimental
Therapeutics Network at Cancer Care Ontario. She will continue her role
Queen's University and the Canadian Cancer Society would like to extend
their gratitude to Dr Elizabeth Eisenhauer for the tremendous support
she has provided by acting as interim director of the NCIC CTG. She
will continue in the role until September 1.
About the NCIC Clinical Trials Group
The NCIC Clinical Trials Group (NCIC CTG) is a cancer clinical trials
cooperative group that conducts phase I-III trials testing anticancer
and supportive therapies across Canada and internationally. It is a
national research program of the Canadian Cancer Society. The NCIC
CTG's Central Operations and Statistics Office is located at Queen's
University in Kingston, Ontario, Canada, in the Queen's University
Cancer Research Institute. This national network develops, conducts and
analyzes multi-institutional trials of cancer therapy. Over 60
institutions involved in cancer care in Canada participate in NCIC CTG
studies. The Group also conducts and participates in international
trials in North America, Europe and Australia.
About the Queen's Faculty of Health Sciences
Established by Royal Charter of Queen Victoria in 1841, Queen's
University is one of Canada's leading universities, with an
international reputation for scholarship, research, social purpose and
spirit. The Faculty of Health Sciences comprises 3 schools: medicine,
nursing and rehabilitation therapy. The schools deliver undergraduate
and postgraduate education programs in medicine, nursing, occupational
therapy, physical therapy, and biomedical and population sciences to
About the Canadian Cancer Society
The Canadian Cancer Society is a national, community-based organization
of volunteers whose mission is to eradicate cancer and enhance the
quality of life of people living with cancer. Thanks to our donors and
volunteers, the Society has the most impact, against the most cancers,
in the most communities in Canada. Building on our progress, we are
working with Canadians to change cancer forever. For more information,
visit cancer.ca or call our toll-free bilingual Cancer Information
Service at 1-888-939-3333 (TTY 1-866-786-3934).
Image with caption: "Dr Janet Dancey (CNW Group/Canadian Cancer Society (National Office))". Image available at: http://photos.newswire.ca/images/download/20140404_C8669_PHOTO_EN_38837.jpg
SOURCE: Canadian Cancer Society (National Office)
For further information:
Sasha Anopina, Bilingual Communications Specialist, Canadian Cancer Society, firstname.lastname@example.org, 416-934-5338; Peter Aitken, Communications Officer, Office of the Dean, Faculty of Health Sciences, Queen's University, email@example.com, 613-453-4237